NL-OMON24209招募中不适用
The effect of stopping the H2-antagonist ranitidine in premedication regimens during paclitaxel treatment.
none0 个研究点目标入组 366 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 366
研究概览
简要总结
A
研究设计
- 研究类型
- Observational non invasive
入排标准
入选标准
- •In order to be eligible to participate in this study, a patient must meet the following criteria:
- •- Age =18 years;
- •- Planned treatment with regular paclitaxel based chemotherapy for any indication and with any dose.
排除标准
- •A potential participant who meets any of the following criteria will be excluded in this study:
- •- Prior treatment with a paclitaxel-based regimen;nal reflux and ulcer disease.
研究者
相似试验
进行中（未招募）
1 期
A study that investigates whether ranitidine has a added value in the prevention of paclitaxel-induced allergic reactionsEUCTR2017-003535-11-NLErasmus MC554
已完成
不适用
Effect of an H2 receptor antagonist or a proton pump inhibitor on prevention of bleeding and healing of the endoscopic submucosal dissection-induced ulceration :a prospective randomized controlled trialearly gastric cancer,gastric adenomaJPRN-UMIN000001069Division of Gastroenterology,Department of Internal Medicine, Keio University120
已完成
1 期
Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy ParticipantsHealthyNCT05338502Eli Lilly and Company20
尚未招募
不适用
Effects of temporary discontinuation of antihypertensive treatment in older patients with cognitive impairment: A randomised controlled trial.antihypertensive therapy - cognitive functioning - elderlyNL-OMON26485eiden University Medical Center400
已完成
不适用
Therapeutic effect of a histamine H2 receptor antagonist on prokinetic agent-resistant symptomatic chronic gastritischronic gastritisJPRN-UMIN000002248Shimane University20